Related Experiment Video
Updated: Jan 5, 2026

Generation of a Rat Model of Acute Liver Failure by Combining 70% Partial Hepatectomy and Acetaminophen
Published on: November 27, 2019
Emerging and established modes of cell death during acetaminophen-induced liver injury
Hartmut Jaeschke1, Anup Ramachandran2, Xiaojuan Chao2
1Department of Pharmacology, Toxicology and Therapeutics, University of Kansas Medical Center, 3901 Rainbow Blvd, MS 1018, Kansas City, KS, 66160, USA. hjaeschke@kumc.edu.
Abstract:
Acetaminophen (APAP)-induced liver injury is an important clinical and toxicological problem. Understanding the mechanisms and modes of cell death are vital for the development of therapeutic interventions. The histological and clinical features of APAP hepatotoxicity including cell and organelle swelling, karyolysis, and extensive cell contents release lead to the characterization of the cell death as oncotic necrosis. However, the more recent identification of detailed signaling mechanisms of mitochondrial dysfunction, the amplification mechanisms of mitochondrial oxidant stress and peroxynitrite formation by a mitogen-activated protein kinase cascade, mechanisms of the mitochondrial permeability transition pore opening and nuclear DNA fragmentation as well as the characterization of the sterile inflammatory response suggested that the mode of cell death is better termed programmed necrosis. Additional features like mitochondrial Bax translocation and cytochrome c release, mobilization of lysosomal iron and the activation of receptor-interacting protein kinases and the inflammasome raised the question whether other emerging modes of cell death such as apoptosis, necroptosis, ferroptosis and pyroptosis could also play a role. The current review summarizes the key mechanisms of APAP-induced liver injury and compares these with key features of the newly described modes of cell death. Based on the preponderance of experimental and clinical evidence, the mode of APAP-induced cell death should be termed programmed necrosis; despite some overlap with other modes of cell death, APAP hepatotoxicity does not fulfill the characteristics of either apoptosis, necroptosis, ferroptosis, pyroptosis or autophagic cell death.
Insights
Acetaminophen (APAP) causes liver injury through programmed necrosis, not other cell death types. Understanding APAP hepatotoxicity mechanisms is key for developing treatments.
Area of Science:
- Hepatology
- Toxicology
- Cell Biology
Background:
- Acetaminophen (APAP)-induced liver injury is a significant clinical issue.
- Identifying cell death mechanisms is crucial for therapeutic development.
Purpose of the Study:
- To review APAP hepatotoxicity mechanisms.
- To compare APAP-induced cell death with emerging cell death modalities.
Main Methods:
- Review of experimental and clinical evidence on APAP hepatotoxicity.
- Comparison of APAP-induced cell death features with apoptosis, necroptosis, ferroptosis, pyroptosis, and autophagic cell death.
Main Results:
- APAP hepatotoxicity involves mitochondrial dysfunction, oxidant stress, and DNA fragmentation.
- Features suggest programmed necrosis, with some overlap with other cell death types.
- APAP-induced cell death does not fully align with apoptosis, necroptosis, ferroptosis, pyroptosis, or autophagic cell death.
Conclusions:
- APAP-induced liver injury is best characterized as programmed necrosis.
- This classification is based on the preponderance of evidence, despite some shared features with other cell death pathways.
Related Concept Videos
Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
Necrosis
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Apoptosis
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Acute Kidney Injury II: Pathophysiology

